Página inicial>Investigação clínica>Ensaios clínicos>REP1 Gene Replacement Therapy for Choroideremia
How to use the speech recognition tool?
REGENERATE - NCT02407678
REP1 Gene Replacement Therapy for Choroideremia
REP1 Gene Replacement Therapy for Choroideremia
Type: Interventional
Status of the trial: Active, Not recruiting
Orphan Drug Recognition: Yes
Inclusion
- Opening Date: 2016-08-01
- Closing Date: 2021-08-01
Criteria
Children: No
Adults: Yes
Funder Type: other
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Retinal Rare Eye Diseases (WG1)